Collectively, this study uncovers a previously unrecognized regulatory mechanism of PDC assembly and activity, revealing a pro-tumorigenic mechanism that could also serve as a potentially effective therapeutic target in future clinical interventions for HCC. This evidence concerns the gene PDC and hepatocellular carcinoma.